DRKS00022325招募中未知
Cardiovascular Offensive by the Medizinische Praxisnetz Neumünster e.V.
nterstützt mit Mitteln des Strukturfonds zur Förderung anerkannter Praxisnetze gemäß §87b SGB V der Kassenärztlichen Vereinigung Schleswig-Holstein (KVSH)0 个研究点目标入组 600 人开始时间: 2020年8月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients will be included if they have been treated with medication for arterial hypertension for at least six months and have given their written consent.
排除标准
- •Patients will be excluded if they have not reached the age of 18 yet or cannot complete the questionnaire due to insufficient German language skills.
研究者
相似试验
进行中（未招募）
不适用
Comparison between 2 different hydration strategies (saline solution vs carbonati) for the prevention of contrast induced nephropaty in patients at risk for heart failure undergoing coronary angiography or interventioPatients undergoing coronary angiography or angioplastyMedDRA version: 14.1Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-003611-37-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA' DI NOVARA240
进行中（未招募）
不适用
PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecrosiS in elective coronary angioplasty. A prospective double-blind randomized trial (PREVENT ICARUS) trial - PREVENT-ICARUSElective coronary angioplastyMedDRA version: 9.1Level: SOCClassification code 10047065EUCTR2009-013681-92-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
进行中（未招募）
不适用
Status of medical management of vascular risk factors before and after stroke in KoreaDiseases of the circulatory systemKCT0000671Seoul National University Hospital54,000
已完成
不适用
Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)JPRN-UMIN000000492agoya University160
招募中
不适用
Investigating cardiovascular adverse events related to cancer treatment: a study of extreme toxicity using induced pluripotent stem cellscardiovascular adverse events after cancer treatment1008220610027655NL-OMON44465niversitair Medisch Centrum Groningen48